ASML news is wild—sold out through 2028 but the stock's getting trashed anyway, classic sell-the-news slap. Chart's bleeding: RSI cooled to 38, price broke under both WMAs, and that 3M share volume day screams capitulation, not accumulation. Daily lower highs since Oct 1 tell the story. AI demand is real, but the tape says wait. SELL the bounce, or hold cash and watch closely.

Crowd thinks sold-out machines equals safe AI buy; tape disagrees. RSI slid to 38, both weighted MAs sit above price like roofs, and late selling on 2.9M volume says supply stepped in. The scoop is demand outruns ASML, but valuation outruns hope. This isn’t a screaming oversold rebound setup; it’s a sell-the-good-news fade. My call: SELL into strength, or wait for reclaim 1750 before buying.

The headlines want you to swoon over sold-out order books through 2028, but the market is clearly voting elsewhere. Despite the AI capacity rhetoric, institutions dumped shares into the close, doubling volume as the price broke below 1650. Trading well under both the 9- and 21-period moving averages with RSI sliding toward 38, this breakdown reflects distribution, not opportunity. When euphoric commentary clashes with heavy institutional selling, trust the tape. SELL.

Geopolitics is giving ASML a headache. 📉 New export ban talk is the main event, and the tape shows it: a nasty gap down on March 30th, heavy volume, and the stock struggling to recover. The 9-day EMA just slipped under the 21-day—a bearish kiss. RSI is weak but not washed out yet. This feels like the market pricing in real pain. Until the regulatory fog clears, this is a SELL. The chart’s telling a story the news confirms. #ChipWars

The news is pure rocket fuel: a record $8B order and a path to double revenue by 2030. 🚀 But the stock's been selling the news! The 9-day WMA just crashed below the 21-day, RSI is dipping into oversold territory (41.6), and today's chart shows a steady slide all day. This is a classic "buy the rumor, sell the news" hangover. Wait for the dip-buyers to step in. Hold for now. #PatiencePays

"ASML’s earnings tumble has everyone sweating, but here’s the tea: RSI is flirting with oversold (39.6), and the 9-day WMA just crossed below the 21-day—classic 'ouch' momentum. 📉 News screams 'growth concerns,' but volume’s oddly chill, like the market’s napping on this dip. Chart? Messy, no clear pattern—just a sad slide. If you’re a long-term AI bull, this *might* be your discount ticket… but for now? Hold the FOMO. #PatiencePays"

"ASML’s stock is getting tossed like a salad—earnings beat but guidance spooked the market. 📉 RSI’s dipping near oversold (35.5), and those WMAs are sloping down like a ski jump. News says ‘buy the dip,’ but volume screams panic selling. Chart’s a mess—no clean patterns, just turbulence. If you’ve got steel nerves, this could be a contrarian play, but for most? Hold and watch for stabilization. #ChipWars ain’t over yet."

ASML's stock is in a clear downtrend 📉, with both the 9-day and 21-day EMAs sloping downward and prices breaking below key levels. The RSI at 32.55 (April 4) hints at oversold conditions, but volume spikes on down days suggest strong selling pressure. News highlights mixed sentiment—tariff worries vs. AI optimism. No clear reversal pattern yet, but if RSI dips below 30, contrarians might see a buying opportunity. For now, it’s a "hold" unless bullish confirmation emerges. 🚀 or �? Waiting game.